Performa Ltd (US)’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-250
Closed -$3K 78
2022
Q3
$3K Buy
+250
New +$4.32K ﹤0.01% 65
2022
Q1
Sell
-150
Closed -$3K 68
2021
Q4
$3K Buy
150
+50
+50% +$1.07K ﹤0.01% 45
2021
Q3
$2K Buy
+100
New +$2.41K ﹤0.01% 51

Other funds holding PAHC

Performa Ltd (US)'s PAHC Position: Q4 2022 in Review

Performa Ltd (US) sold out of Phibro Animal Health (PAHC) in Q4 2022, closing a stake of 250 shares — an estimated $3K sold.

Performa Ltd (US) first reported a position in PAHC in Q3 2021 and held it in 3 quarters. The position peaked at $3K in Q3 2022. 132 funds tracked by Wall St. Rank hold PAHC as of Q4 2022.

  • Performa Ltd (US) reported no remaining Phibro Animal Health position as of Q4 2022 after selling out during the quarter.
  • Performa Ltd (US) sold 250 Phibro Animal Health shares in Q4 2022, an estimated $3K.
  • Performa Ltd (US) first reported a position in Phibro Animal Health in Q3 2021 and held it in 3 quarters.
  • Performa Ltd (US)'s Phibro Animal Health position peaked at $3K in Q3 2022.
  • 132 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2022.

Based on Performa Ltd (US)'s 13F filing for Q4 2022, filed 3 Feb 2023.